# Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder

> **NCT01518972** · PHASE2 · COMPLETED · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 30 (actual)

## Conditions studied

- Alcohol Abuse
- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Prazosin
- **DRUG:** Placebo medication

## Key facts

- **NCT ID:** NCT01518972
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-08-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518972, "Prazosin for Alcohol Dependence and Posttraumatic Stress Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01518972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*